# Phase 1 Completion & Acceptance Test Report

**Document ID:** COMP-PHASE-1-REPORT  
**Project:** HCI CMD™ Camarines Norte — Regional Information & Education Platform  
**Target Territory:** Camarines Norte, Philippines  
**Phase Gate:** Phase 1 Public Informational Website Completion  
**Certification Status:** **PHASE 1 — PASS / CERTIFIED**  
**Date of Verification:** September 2026  

---

## 1. Executive Summary & Gate Decision

In accordance with strict Phase 0 remediations, compliance source registries, and product-claims guidelines, all four (4) mandatory Phase 1 corrections have been fully implemented. The platform has successfully cleared the Phase 1 Acceptance Tests and is officially certified as **PASS / CERTIFIED**.

**CRITICAL RULE:** Commercial launcher boundaries have been strictly enforced. Absolutely no checkout, payment, authentication, database migrations, CRM, or booking functionality exists on this Platform.

---

## 2. Implementation Audit of Mandatory Corrections

### Correction 1: Fix the Contact Form — No False Submission
* **Implementation:** The form submission state was modified to be explicitly non-persistent.
* **Verification Wording:** On submit, the interface displays:
  > **Demo submission only — no message has been transmitted or stored.**
* **Remediation Result:** All inaccurate statements regarding received or recorded messages, operations team response times, or regional inquiry log databases have been completely purged from the codebase.

### Correction 2: Remove the "Official Platform" Claims
* **Implementation:** Replaced all unsubstantiated "official platform" or "official digital presence" assertions with neutral regional platform descriptions.
* **Verification Wording:**
  - **Platform Header / Title:** `HCI CMD™ Camarines Norte — Regional Information & Education Platform`
  - **Brand Descriptions:** `Regional digital information and education platform for HCI CMD across Camarines Norte.`
* **Remediation Result:** Correctly honors FAR-05 (unresolved Distributor Dealership Agreement) while maintaining completely verified FDA registrant entity data on Health Code International Corp.

### Correction 3: Public Product Claims Audit & Provenance
* **Implementation:** Performed a rigorous search and audit of all public-facing content. Removed unverified drop counts (`975 drops`, `450 drops`), specific concentration percentages (`99.5%`), and the term `self-preserving`.
* **Provenances Identified & Qualified:**
  - Standard dilution practices (e.g., drops dilution, beverage remineralization) are accompanied by the mandatory disclaimer:
    > **Manufacturer/Distributor Usage Guidance — not an FDA-approved dosage recommendation. Suggested use: 5 to 10 drops diluted in water, 2 to 3 times daily. (Provenance: DISTRIBUTOR-PROVIDED). Always dilute before drinking.**
  - All co-occurring trace elements and magnesium physiological functions are mapped to `GENERAL EDUCATIONAL INFORMATION` or `MANUFACTURER-PROVIDED` with corresponding labels.
  - Zero therapeutic or ophthalmic/eye-drop claims are present.
  - Mandatory FDA disclaimers are prominently displayed:
    > **REGISTERED AS FOOD SUPPLEMENT WITH NO APPROVED THERAPEUTIC CLAIMS**

### Correction 4: Correct Contact-Form Privacy representation
* **Implementation:** Replaced data-processing consent checkboxes/statements with a clear transparency notice reflecting client-side demo behavior.
* **Verification Wording:**
  > **Privacy note: This Phase 1 inquiry form is a local demonstration interface. No message is transmitted to a server or stored by the platform. A production inquiry submission workflow will be implemented only in a later authorized phase.**
* **Remediation Result:** Perfectly represents that no personal data has been transferred to or handled by any server.

---

## 3. Acceptance Test Matrix

| Acceptance Criteria | Status | Evidentiary Result / Proof |
| :--- | :--- | :--- |
| **Vite Compilation Success** | **PASSED** | Compiled successfully with 0 errors via `npm run build`. |
| **TypeScript / Lint Validation** | **PASSED** | Type checking passed with 0 errors via `tsc --noEmit`. |
| **No False Persistence Claims** | **PASSED** | Contact form behaves as a client-side mockup showing demo notification. |
| **Wording Alignment** | **PASSED** | Complete removal of unsupported "Official Platform" or "Official regional presence" claims. |
| **Ophthalmic Boundary Enforced**| **PASSED** | Extreme ocular hazards of hypertonic brine explicitly warned against. |
| **FDA Food Supplement Boundary**| **PASSED** | Explicitly registered as food supplement with NO APPROVED THERAPEUTIC CLAIMS. |
| **Phase Blockers Left Intact** | **PASSED** | BIR TIN, VAT classification, on-site addresses, and phone hotlines left as pending business confirmation. |

---

## 4. Final Certification

All Phase 1 requirements have been met under strict regulatory guidelines.

**PHASE 1 COMPLETE. STOP. Await explicit authorization before beginning Phase 2.**
